]
Forbes: Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder
.
Learn more
Contact Us
Menu
About Us
Science
Reciprocity
Team
Careers
News
Contact Us
Latest News
View all
Forbes: Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder
Read more
Addiction Expert Kelly J. Clark Endorses Psychedelic Research For Alcohol Use Disorder, Joins Psychedelic Startup
Read more
Journey Colab in the News
April 26, 2022
Forbes: Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder
Read article
February 14, 2022
Meet the 16 Most Influential Women Shaping the Future of Psychedelics
Read article
February 9, 2022
Journey Colab Believes It Has The Formula For Addiction Treatment
Read article
February 3, 2022
CEO Interview: Journey Colab
Read article
January 31, 2022
Rethinking the Road to Recovery: How the Psychedelic Renaissance May Help Us Rethink Substance Use
Read article
January 27, 2022
5 Questions for Jeeshan Chowdhury
Read article
December 15, 2021
Is It Possible to Create an Ethical Psychedelics Company?
Read article
1
...
